Endo International plc: Endo Launches First Generic Version of CUVPOSA (glycopyrrolate) Oral Solution

DUBLIN, Jan. 4, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first generic

Related Keywords

Canada ,Dublin ,Ireland ,Canadian ,Jon Holden ,Prnewswire Endo International ,Exchange Commission ,Linkedin ,Merz Pharmaceuticals ,Drug Administration ,Nasdaq ,Par Pharmaceutical ,Abbreviated New Drug ,Senior Vice President ,General Manager ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Kendo ,Nternational ,Aunches ,First ,Generic ,Version ,Uvposa ,Lycopyrrolate ,Mural ,Solution ,